Franco Leoni

2.1k total citations
24 papers, 541 citations indexed

About

Franco Leoni is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Franco Leoni has authored 24 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Franco Leoni's work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Neutropenia and Cancer Infections (6 papers). Franco Leoni is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Neutropenia and Cancer Infections (6 papers). Franco Leoni collaborates with scholars based in Italy, United States and Switzerland. Franco Leoni's co-authors include Paul R. Julsrud, Douglas D. Mair, Francisco J. Puga, Felicetto Ferrara, Salvatore Palmieri, Stefania Ciolli, Giacomo Gianfaldoni, Alberto Bosi, Valeria Santini and Elisabetta Antonioli and has published in prestigious journals such as Blood, Cancer and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Franco Leoni

24 papers receiving 522 citations

Peers

Franco Leoni
J. H. Bourhis France
A Comelli Italy
Omar Racchi Italy
Giuseppe Irrera Italy
Michihiro Uchiyama Japan
Michael S. Milder United States
Afshin Ameri United States
Rachael P. Jackman United States
Abdul Hameed Pakistan
J-H Bourhis France
J. H. Bourhis France
Franco Leoni
Citations per year, relative to Franco Leoni Franco Leoni (= 1×) peers J. H. Bourhis

Countries citing papers authored by Franco Leoni

Since Specialization
Citations

This map shows the geographic impact of Franco Leoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Leoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Leoni more than expected).

Fields of papers citing papers by Franco Leoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Leoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Leoni. The network helps show where Franco Leoni may publish in the future.

Co-authorship network of co-authors of Franco Leoni

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Leoni. A scholar is included among the top collaborators of Franco Leoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Leoni. Franco Leoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciolli, Stefania, et al.. (2008). The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma. British Journal of Haematology. 141(6). 814–819. 33 indexed citations
2.
Ferrara, Felicetto, Salvatore Palmieri, & Franco Leoni. (2007). Clinically useful prognostic factors in acute myeloid leukemia. Critical Reviews in Oncology/Hematology. 66(3). 181–193. 60 indexed citations
3.
4.
Gianfaldoni, Giacomo, Francesco Mannelli, Michela Baccini, et al.. (2006). Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study. British Journal of Haematology. 134(1). 54–57. 34 indexed citations
5.
Bassan, Renato, Orietta Spinelli, Elena Oldani, et al.. (2005). Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL).. Blood. 106(11). 1836–1836. 1 indexed citations
6.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). Leukemia & lymphoma. 46(2). 233–238. 13 indexed citations
7.
Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of Two Regimens for the Treatment of Elderly Patients with Acute Lymphoblastic Leukaemia (ALL).. Blood. 104(11). 4490–4490. 4 indexed citations
8.
Offidani, Massimo, Laura Corvatta, Riccardo Centurioni, et al.. (2003). High-dose daunorubicin as liposomal compound (Daunoxome®) in elderly patients with acute lymphoblastic leukemia1. The Hematology Journal. 4(1). 47–53. 18 indexed citations
9.
Caporale, Roberto, et al.. (2003). In vitro antileukemic effect of a new anthracycline analogue, MEN 11079. Leukemia Research. 27(12). 1125–1134. 2 indexed citations
10.
Ferrara, Felicetto, Salvatore Palmieri, Barbara Pocali, et al.. (2002). De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G‐CSF (FLAG). European Journal Of Haematology. 68(4). 203–209. 31 indexed citations
11.
Leoni, Franco, Giacomo Gianfaldoni, Mario Annunziata, et al.. (2002). Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.. PubMed. 87(5). 485–9. 26 indexed citations
12.
Ferrara, Felicetto, Fortunato Morabito, Roberto Latagliata, et al.. (2001). Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission.. PubMed. 86(8). 814–20. 22 indexed citations
13.
Ferrara, Felicetto, Franco Leoni, António E. Pinto, et al.. (1999). Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes. Cancer. 86(10). 2006–2013. 25 indexed citations
14.
Linari, Silvia, Alessandro M. Vannucchi, Franco Leoni, et al.. (1998). Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias. British Journal of Haematology. 102(5). 1335–1337. 13 indexed citations
15.
16.
Leoni, Franco, et al.. (1992). Continuous-Infusion Cyclophosphamide in Combination with Teniposide and Dexamethasone in Refractory Myeloma. Leukemia & lymphoma. 7(5-6). 481–487. 2 indexed citations
17.
Leoni, Franco, et al.. (1991). Teniposide, dexamethasone and continuous‐infusion cyclophosphamide in advanced refractory myeloma. British Journal of Haematology. 77(2). 180–184. 6 indexed citations
18.
Puga, Francisco J., Franco Leoni, Paul R. Julsrud, & Douglas D. Mair. (1989). Complete repair of pulmonary atresia, ventricular septal defect, and severe peripheral arborization abnormalities of the central pulmonary arteries. Journal of Thoracic and Cardiovascular Surgery. 98(6). 1018–1029. 78 indexed citations
19.
Puga, Francisco J., Franco Leoni, Paul R. Julsrud, & Douglas D. Mair. (1989). Complete repair of pulmonary atresia, ventricular septal defect, and severe peripheral arborization abnormalities of the central pulmonary arteries. Experience with preliminary unifocalization procedures in 38 patients.. PubMed. 98(6). 1018–28; discussion 1028. 92 indexed citations
20.
Leoni, Franco, et al.. (1988). 13-cis-Retinoic Acid Treatment in Patients with Myelodysplastic Syndrome. Acta Haematologica. 80(1). 8–12. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. H. Bourhis Breakdown of academic impact, for papers by A Comelli Breakdown of academic impact, for papers by Omar Racchi Breakdown of academic impact, for papers by Giuseppe Irrera Breakdown of academic impact, for papers by Michihiro Uchiyama Breakdown of academic impact, for papers by Michael S. Milder Breakdown of academic impact, for papers by Afshin Ameri Breakdown of academic impact, for papers by Rachael P. Jackman Breakdown of academic impact, for papers by Abdul Hameed Breakdown of academic impact, for papers by J-H Bourhis
Rankless by CCL
2026